Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a23eb5d7d873a9fe

Jump to content

// Workers AI · dad joke modeWhat did HLA-B44 say to its date? "You're a match.

From Wikipedia, the free encyclopedia
Illustration of HLA-B with peptide in the binding pocket.
HLA-B (alpha)-β2MG with bound peptide
major histocompatibility complex (human), class I, B44
Alleles B*4401, 4402, 4403 . .
Structure (See HLA-B)
Shared data
Locus chr.6 6p21.31

HLA-B44 (B44) is an HLA-B serotype. The serotype identifies the B*44 gene-allele protein products of HLA-B.[1]

B44 is a split antigen of the broad antigen B12, and is a sister type of B45.

Serotype

[edit]
Serotypes B44, B12, and B45 recognition of the
HLA B*44 gene products[2]
B*44B44 B12 B45Sample
allele%%%size (N)
*4402986959
*4403942854
*44046542
*440592130
*4406449
B*4401 was shown to be B*4402 after errors corrected.
Alleles link-out to IMGT/HLA Database at EBI

Alleles

[edit]

Disease

[edit]

HLA-B44 increases recurrent sinopulmonary infections.[3] Protective effects: HLA-B44 appears to be protective against autoimmune lymphoproliferative syndrome in patients with C95 defect (ALPS type Ia).[4] B44 may be a cofactor in ankylosing spondylitis[5]

References

[edit]
  1. Marsh, S. G.; Albert, E. D.; Bodmer, W. F.; Bontrop, R. E.; Dupont, B.; Erlich, H. A.; Fernández-Viña, M.; Geraghty, D. E.; Holdsworth, R.; Hurley, C. K.; Lau, M.; Lee, K. W.; Mach, B.; Maiers, M.; Mayr, W. R.; Müller, C. R.; Parham, P.; Petersdorf, E. W.; Sasazuki, T.; Strominger, J. L.; Svejgaard, A.; Terasaki, P. I.; Tiercy, J. M.; Trowsdale, J. (2010). "Nomenclature for factors of the HLA system, 2010". Tissue Antigens. 75 (4): 291–455. doi:10.1111/j.1399-0039.2010.01466.x. PMC 2848993. PMID 20356336.
  2. derived from IMGT/HLA
  3. Johnston DT, Mehaffey G, Thomas J, et al. (June 2006). "Increased frequency of HLA-B44 in recurrent sinopulmonary infections (RESPI)". Clin. Immunol. 119 (3): 346–50. doi:10.1016/j.clim.2006.02.001. PMID 16542878.
  4. Vacek MM, Schäffer AA, Davis J, et al. (January 2006). "HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia)". Clin. Immunol. 118 (1): 59–65. doi:10.1016/j.clim.2005.09.006. PMID 16257267.
  5. Purrmann J, Zeidler H, Bertrams J, et al. (November 1988). "HLA antigens in ankylosing spondylitis associated with Crohn's disease. Increased frequency of the HLA phenotype B27,B44". J. Rheumatol. 15 (11): 1658–61. PMID 3266250.